Intuitive Surgical (NASDAQ:ISRG) Price Target Raised to $675.00

Intuitive Surgical (NASDAQ:ISRG) had its price target increased by JPMorgan Chase & Co. from $575.00 to $675.00 in a research report report published on Friday,Benzinga reports. JPMorgan Chase & Co. currently has an overweight rating on the medical equipment provider’s stock.

Several other brokerages also recently weighed in on ISRG. Morgan Stanley upgraded shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and increased their price target for the stock from $522.00 to $650.00 in a report on Monday, December 2nd. Royal Bank of Canada increased their price objective on shares of Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a research note on Friday, October 18th. Raymond James boosted their target price on shares of Intuitive Surgical from $500.00 to $540.00 and gave the company an “outperform” rating in a research report on Monday, October 14th. Oppenheimer reaffirmed a “market perform” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Finally, Evercore ISI reissued a “cautious” rating on shares of Intuitive Surgical in a report on Friday, October 18th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average target price of $583.83.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $584.05 on Friday. Intuitive Surgical has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The company has a market cap of $208.03 billion, a PE ratio of 93.90, a PEG ratio of 5.19 and a beta of 1.39. The business’s 50-day simple moving average is $547.16 and its two-hundred day simple moving average is $504.78.

Insiders Place Their Bets

In other news, insider Jamie Samath sold 269 shares of the firm’s stock in a transaction dated Monday, November 11th. The shares were sold at an average price of $539.89, for a total value of $145,230.41. Following the transaction, the insider now directly owns 8,757 shares of the company’s stock, valued at approximately $4,727,816.73. This trade represents a 2.98 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, EVP Robert Desantis sold 188 shares of the firm’s stock in a transaction that occurred on Tuesday, October 29th. The stock was sold at an average price of $506.52, for a total transaction of $95,225.76. Following the completion of the transaction, the executive vice president now directly owns 5,506 shares in the company, valued at $2,788,899.12. This trade represents a 3.30 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 42,453 shares of company stock worth $22,059,506. Company insiders own 0.90% of the company’s stock.

Hedge Funds Weigh In On Intuitive Surgical

A number of hedge funds have recently modified their holdings of the business. State Street Corp grew its stake in shares of Intuitive Surgical by 1.4% in the third quarter. State Street Corp now owns 15,050,121 shares of the medical equipment provider’s stock worth $7,393,673,000 after acquiring an additional 210,363 shares in the last quarter. FMR LLC increased its holdings in Intuitive Surgical by 8.3% during the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock worth $5,389,765,000 after purchasing an additional 838,793 shares during the period. Geode Capital Management LLC raised its position in Intuitive Surgical by 1.9% in the 3rd quarter. Geode Capital Management LLC now owns 7,512,925 shares of the medical equipment provider’s stock valued at $3,677,194,000 after purchasing an additional 143,440 shares in the last quarter. Fisher Asset Management LLC boosted its stake in shares of Intuitive Surgical by 1.8% in the 3rd quarter. Fisher Asset Management LLC now owns 4,782,381 shares of the medical equipment provider’s stock valued at $2,349,441,000 after buying an additional 86,208 shares during the period. Finally, Baillie Gifford & Co. grew its position in shares of Intuitive Surgical by 0.6% during the third quarter. Baillie Gifford & Co. now owns 3,848,547 shares of the medical equipment provider’s stock worth $1,890,676,000 after buying an additional 24,183 shares in the last quarter. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.